Climb Bio Inc. – Filings and Transcripts

NASDAQ: CLYM
Share price (10/1/26): $11.07
Market cap (10/1/26): $636 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement

Shelf registration

Exempt offering of securities

Registration of securities for employees

Ownership Filter

RA Capital Healthcare Fund LP, Ra Capital Management, L.P., Kolchinsky Peter, Shah Rajeev M., RA Capital Nexus Fund, L.P., RA Capital Nexus Fund II, L.P., RA Capital Nexus Fund III, L.P.

Thomas Stephen Basil

Thomas Stephen Basil

MPM BioImpact LLC

News Filter

Announces CLYM116 Phase 1 Data Demonstrating Prolonged Half-Life and Best-In-Class APRIL Suppression Supporting Every-12-Week Dosing in IgA Nephropathy

Reports Second Quarter 2026 Financial Results and Provides Business Updates

Change in Directors, Officers or Compensation

Material Definitive Agreement, Other Events, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission

Scanned paper annual report submission